{"id":1309,"date":"2018-07-10T09:28:55","date_gmt":"2018-07-10T09:28:55","guid":{"rendered":"http:\/\/event.roseliassociates.com\/meetingtitle\/?page_id=1309"},"modified":"2024-03-19T20:06:53","modified_gmt":"2024-03-19T20:06:53","slug":"home","status":"publish","type":"page","link":"https:\/\/event.roseliassociates.com\/pdtherapeutics\/","title":{"rendered":"Home"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"1309\" class=\"elementor elementor-1309\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-7d6d1d5 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"7d6d1d5\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-762c206\" data-id=\"762c206\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-8aea032 elementor-widget elementor-widget-heading\" data-id=\"8aea032\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Advances in Therapeutics Development for Parkinson\u2019s Disease<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-40db94e elementor-widget elementor-widget-spacer\" data-id=\"40db94e\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-03e847c elementor-widget elementor-widget-text-editor\" data-id=\"03e847c\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h5 style=\"text-align: center;\"><span style=\"color: #000000;\"><strong>April 23 \u2013 24, 2024<\/strong><\/span><br \/><span style=\"color: #000000;\"><strong>Location: 6001 Executive Blvd, Rockville, MD 20852 \/ Zoom<\/strong><\/span><\/h5><p>Despite substantial public and private interest in developing therapeutics for the Parkinson\u2019s disease (PD) community, there persists separation between disease understanding and development of drugs to target these processes in Parkinson\u2019s patients. The NINDS is convening a hybrid workshop with the overarching goal to (1) delineate what the crucial elements of those gaps are and (2) determine how to close those gaps as a community of stakeholders, including academic researchers, industry partners, non-profit organizations, and people with lived experience of Parkinson\u2019s Disease.<\/p><p>This workshop is co-chaired by <strong>Alice Chen-Plotkin<\/strong>, <b>MD<\/b>, Parker Family Professor of Neurology, University of Pennsylvania School of Medicine and <strong>William Martin<\/strong>, <b>PhD<\/b>, Global Therapeutic Area Head, Neuroscience at Johnson &amp; Johnson Innovative Medicine<\/p><p>For further information, please contact Neel Dhruv <a href=\"mailto:neel.dhruv@nih.gov\" target=\"_blank\" rel=\"noopener\"><span style=\"text-decoration: underline;\">neel.dhruv@nih.gov.<\/span><\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c872283 elementor-widget elementor-widget-spacer\" data-id=\"c872283\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Advances in Therapeutics Development for Parkinson\u2019s Disease April 23 \u2013 24, 2024Location: 6001 Executive Blvd, Rockville, MD 20852 \/ Zoom Despite substantial public and private interest in developing therapeutics for the Parkinson\u2019s disease (PD) community, there persists separation between disease understanding and development of drugs to target these processes in Parkinson\u2019s patients. The NINDS is&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1309","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/event.roseliassociates.com\/pdtherapeutics\/wp-json\/wp\/v2\/pages\/1309","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/event.roseliassociates.com\/pdtherapeutics\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/event.roseliassociates.com\/pdtherapeutics\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/event.roseliassociates.com\/pdtherapeutics\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/event.roseliassociates.com\/pdtherapeutics\/wp-json\/wp\/v2\/comments?post=1309"}],"version-history":[{"count":160,"href":"https:\/\/event.roseliassociates.com\/pdtherapeutics\/wp-json\/wp\/v2\/pages\/1309\/revisions"}],"predecessor-version":[{"id":4173,"href":"https:\/\/event.roseliassociates.com\/pdtherapeutics\/wp-json\/wp\/v2\/pages\/1309\/revisions\/4173"}],"wp:attachment":[{"href":"https:\/\/event.roseliassociates.com\/pdtherapeutics\/wp-json\/wp\/v2\/media?parent=1309"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}